BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19748890)

  • 1. Prion-induced activation of cholesterogenic gene expression by Srebp2 in neuronal cells.
    Bach C; Gilch S; Rost R; Greenwood AD; Horsch M; Hajj GN; Brodesser S; Facius A; Schädler S; Sandhoff K; Beckers J; Leib-Mösch C; Schätzl HM; Vorberg I
    J Biol Chem; 2009 Nov; 284(45):31260-9. PubMed ID: 19748890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of small GTPase Rab7 activation in prion infection negatively affects a feedback loop regulating neuronal cholesterol metabolism.
    Cherry P; Lu L; Shim SY; Ebacher V; Tahir W; Schatzl HM; Hannaoui S; Gilch S
    J Biol Chem; 2023 Feb; 299(2):102883. PubMed ID: 36623732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation.
    Bate C; Tayebi M; Williams A
    BMC Biol; 2008 Feb; 6():8. PubMed ID: 18269734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An astrocyte cell line that differentially propagates murine prions.
    Tahir W; Abdulrahman B; Abdelaziz DH; Thapa S; Walia R; Schätzl HM
    J Biol Chem; 2020 Aug; 295(33):11572-11583. PubMed ID: 32561641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
    Carroll JA; Race B; Williams K; Striebel J; Chesebro B
    Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
    White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
    Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferon protects neurons from prions in in vivo models.
    Ishibashi D; Homma T; Nakagaki T; Fuse T; Sano K; Satoh K; Mori T; Atarashi R; Nishida N
    Brain; 2019 Apr; 142(4):1035-1050. PubMed ID: 30753318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes.
    Sorensen G; Medina S; Parchaliuk D; Phillipson C; Robertson C; Booth SA
    BMC Genomics; 2008 Mar; 9():114. PubMed ID: 18315872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-cell autonomous astrocyte-mediated neuronal toxicity in prion diseases.
    Kushwaha R; Sinha A; Makarava N; Molesworth K; Baskakov IV
    Acta Neuropathol Commun; 2021 Feb; 9(1):22. PubMed ID: 33546775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
    Cronier S; Laude H; Peyrin JM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic responses to prion disease in rats.
    Herbst A; Ness A; Johnson CJ; McKenzie D; Aiken JM
    BMC Genomics; 2015 Sep; 16(1):682. PubMed ID: 26341492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced neuroinvasion by smaller, soluble prions.
    Bett C; Lawrence J; Kurt TD; Orru C; Aguilar-Calvo P; Kincaid AE; Surewicz WK; Caughey B; Wu C; Sigurdson CJ
    Acta Neuropathol Commun; 2017 Apr; 5(1):32. PubMed ID: 28431576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qki activates Srebp2-mediated cholesterol biosynthesis for maintenance of eye lens transparency.
    Shin S; Zhou H; He C; Wei Y; Wang Y; Shingu T; Zeng A; Wang S; Zhou X; Li H; Zhang Q; Mo Q; Long J; Lan F; Chen Y; Hu J
    Nat Commun; 2021 May; 12(1):3005. PubMed ID: 34021134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyp3a deficiency enhances androgen receptor activity and cholesterol synthesis in the mouse prostate.
    Hashimoto M; Kobayashi K; Yamazaki M; Kazuki Y; Takehara S; Oshimura M; Chiba K
    J Steroid Biochem Mol Biol; 2016 Oct; 163():121-8. PubMed ID: 27137100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SREBP2 Activation Induces Hepatic Long-chain Acyl-CoA Synthetase 1 (ACSL1) Expression in Vivo and in Vitro through a Sterol Regulatory Element (SRE) Motif of the ACSL1 C-promoter.
    Singh AB; Kan CF; Dong B; Liu J
    J Biol Chem; 2016 Mar; 291(10):5373-84. PubMed ID: 26728456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.
    Che L; Chi W; Qiao Y; Zhang J; Song X; Liu Y; Li L; Jia J; Pilo MG; Wang J; Cigliano A; Ma Z; Kuang W; Tang Z; Zhang Z; Shui G; Ribback S; Dombrowski F; Evert M; Pascale RM; Cossu C; Pes GM; Osborne TF; Calvisi DF; Chen X; Chen L
    Gut; 2020 Jan; 69(1):177-186. PubMed ID: 30954949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenetic investigations of prion diseases of humans and animals.
    Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1993 Feb; 339(1288):239-54. PubMed ID: 8097053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neuroprotective role for microglia in prion diseases.
    Zhu C; Herrmann US; Falsig J; Abakumova I; Nuvolone M; Schwarz P; Frauenknecht K; Rushing EJ; Aguzzi A
    J Exp Med; 2016 May; 213(6):1047-59. PubMed ID: 27185853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.